Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 9,200 shares at $18.31 ($168K) on 2025-12-22, disclosed to the SEC on 2025-12-23.
Scheduled sale ($168k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCAX | SELL | 2026-05-26 | $188K | — | Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |